Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125253221 | 12525322 | 1 | I | 20160622 | 20160704 | 20160704 | EXP | JP-CONCORDIA PHARMACEUTICALS INC.-GSH201606-003327 | CONCORDIA | AKINO N,WADA-HIRAIKE O,MATSUMOTO Y,ARIMOTO T,ODA K,KAWANA K. VAGINAL CANCER POSSIBLY CAUSED BY PESSARY AND IMMUNOCOMPROMISED CONDITION: MULTIPLE RISK FACTORS MAY IN?UENCE VAGINAL CANCER DEVELOPMENT. THE JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH 2016 JUN;42(6):748-751. | 67.00 | YR | F | Y | 0.00000 | 20160701 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125253221 | 12525322 | 1 | PS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 21959 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125253221 | 12525322 | 1 | Interstitial lung disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125253221 | 12525322 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125253221 | 12525322 | Vaginal cancer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |